Stay updated on Autologous LN-145 in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Autologous LN-145 in NSCLC Clinical Trial page.

Latest updates to the Autologous LN-145 in NSCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page revision updated from v3.2.0 to v3.3.2, with no apparent changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check24 days agoChange DetectedAdded numerous new trial sites across Spain, France, Italy, Canada, and the United States, expanding the study's geographic footprint.SummaryDifference3%

- Check39 days agoChange DetectedThere are no significant changes between the two screenshots of the Study Details page (NCT04614103). The content appears unchanged.SummaryDifference0.2%

- Check67 days agoChange Detected- Added a government funding notice and open status details (affects trust and usage guidance). - Updated version from v3.1.0 to v3.2.0 and removed the old version reference.SummaryDifference3%

- Check74 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0 and added a support/contact phone number 1-844-845-4682.SummaryDifference0.1%

- Check89 days agoChange DetectedUpdated revision to v3.0.2 and removed the Back to Top element. No changes to core content, pricing, stock, or time slots.SummaryDifference0.2%

Stay in the know with updates to Autologous LN-145 in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Autologous LN-145 in NSCLC Clinical Trial page.